All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!

Nov 5, 2013 · We are not here to make a few medicines. We are here to reimagine how medicines are made. The Recursion mindset is the deep belief and commitment to industrializing drug discovery …

Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …

Since Recursion was founded in 2013, the company has focused on fundamentally shifting the way drugs are made using data and AI – from an emphasis on generating proprietary data using real …

Mar 12, 2025 · Recursion has partnered with two companies – Helix and Tempus — to gain access to extensive multimodal, de-identified patient data – approximately 20 petabytes for just Tempus alone …

Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!

Recursion applies AI/ML across the entire drug discovery and development process, targeting the three main failure points in traditional R&D. The AI then targets failures in: Efficacy (Maps of Biology), …

The release of Boltz-2 – a new machine learning model from MIT and Recursion that cannot only predict the 3D structure of ligand/protein complexes but predict their binding affinity with new levels of speed …

Recursion’s knowledge graph tool evaluates these possibilities through a complex lens of topics of interest in biology and drug discovery – including global trend scores, protein pockets and structure, …